Can egg yolk powder fight brain cancer? small trial begins
NCT ID NCT07364786
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early trial tests whether a dietary supplement called Salovum (made from egg yolk) can reduce pressure inside glioblastoma brain tumors. Ten adults with suspected glioblastoma will take Salovum for two days after a biopsy. Researchers will measure tumor pressure and inflammation before and during treatment. This is a very small, early study focused on safety and biological effects, not a cure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Salovum (egg yolk powder enriched with antisecretory factor)
What this could lead to
If it works, this could point toward a way to reduce tumor pressure and inflammation in glioblastoma, possibly improving outcomes.
What could go wrong
This is a very small early-phase trial with only 10 people. It is designed to measure short-term effects, not to prove the treatment works. There is no guarantee it will lead to a real treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurosurgery, Skane University Hospital
RECRUITINGLund, 221 85, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••